ELF3 (E74 like ETS transcription factor 3)

2003-02-01  

Identity

HGNC
LOCATION
1q32.1
LOCUSID
ALIAS
EPR-1,ERT,ESE-1,ESX
FUSION GENES

Other Information

Locus ID:

NCBI: 1999
MIM: 602191
HGNC: 3318
Ensembl: ENSG00000163435

Variants:

dbSNP: 1999
ClinVar: 1999
TCGA: ENSG00000163435
COSMIC: ELF3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000163435ENST00000359651P78545
ENSG00000163435ENST00000359651A0A024R974
ENSG00000163435ENST00000367283P78545
ENSG00000163435ENST00000367283A0A024R974
ENSG00000163435ENST00000367284P78545
ENSG00000163435ENST00000367284A0A024R974
ENSG00000163435ENST00000446188Q5SR36

Expression (GTEx)

0
50
100
150

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
378328052024Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells.0
384818032024WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8.0
390528362024HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axis.0
378328052024Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells.0
384818032024WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8.0
390528362024HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axis.0
363296202023ESE1/AGR2 axis antagonizes TGF-β-induced epithelial-mesenchymal transition in low-grade pancreatic cancer.4
365954972023MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.1
368404132023An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.7
369888912023ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.2
363296202023ESE1/AGR2 axis antagonizes TGF-β-induced epithelial-mesenchymal transition in low-grade pancreatic cancer.4
365954972023MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.1
368404132023An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.7
369888912023ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.2
345625992022WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma.9

Citation

Dessen P

ELF3 (E74 like ETS transcription factor 3)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40439/gene-fusions/js/meetings/